Zhang W, Huang X
Biomark Res. 2025; 13(1):43.
PMID: 40075527
PMC: 11905658.
DOI: 10.1186/s40364-025-00750-w.
Pindiprolu S, Singh M, Magham S, Kumar C, Dasari N, Gummadi R
Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39907784
DOI: 10.1007/s00210-025-03835-3.
Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X
Front Pharmacol. 2025; 15():1518983.
PMID: 39830353
PMC: 11739168.
DOI: 10.3389/fphar.2024.1518983.
Zhao L, Gui Y, Cai J, Deng X
Mol Cancer. 2025; 24(1):17.
PMID: 39815289
PMC: 11734411.
DOI: 10.1186/s12943-025-02225-w.
Kuang W, Huang J, Yang Y, Liao Y, Zhou Z, Liu Q
PLoS One. 2025; 19(12):e0316463.
PMID: 39775580
PMC: 11684664.
DOI: 10.1371/journal.pone.0316463.
Multifunctional nanocomposites utilizing ruthenium (II) complex/manganese (IV) dioxide nanoparticle for synergistic reinforcing radioimmunotherapy.
Peng J, Quan D, Yang G, Wei L, Yang Z, Dong Z
J Nanobiotechnology. 2024; 22(1):735.
PMID: 39593029
PMC: 11600833.
DOI: 10.1186/s12951-024-03013-2.
TME-Activated MnO/Pt Nanoplatform of Hydroxyl Radical and Oxygen Generation to Synergistically Promote Radiotherapy and MR Imaging of Glioblastoma.
Chen L, Liu M, Wang Y, Wei W, Li Y, Bai Y
Int J Nanomedicine. 2024; 19:11055-11070.
PMID: 39502635
PMC: 11537150.
DOI: 10.2147/IJN.S474098.
Two-dimensional coordination risedronate-manganese nanobelts as adjuvant for cancer radiotherapy and immunotherapy.
Huang Z, Huang S, Song S, Ding Y, Zhou H, Zhang S
Nat Commun. 2024; 15(1):8692.
PMID: 39375342
PMC: 11458765.
DOI: 10.1038/s41467-024-53084-w.
A Novel Manganese Ion Delivery Carrier Promotes Immune Cell Proliferation and Enhances Innate Immune Responses.
Wang L, Tang T, Zuo K, Liu N, Wei Y, Zhu X
ACS Omega. 2024; 9(38):40226-40233.
PMID: 39346829
PMC: 11425805.
DOI: 10.1021/acsomega.4c06497.
Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response.
Liang X, Wang D, Zhao Y, Wang X, Yao S, Huang W
J Nanobiotechnology. 2024; 22(1):535.
PMID: 39227944
PMC: 11373498.
DOI: 10.1186/s12951-024-02809-6.
A Bioactive Injectable Hydrogel Regulates Tumor Metastasis and Wound Healing for Melanoma via NIR-Light Triggered Hyperthermia.
Liu X, Shen M, Bing T, Zhang X, Li Y, Cai Q
Adv Sci (Weinh). 2024; 11(26):e2402208.
PMID: 38704692
PMC: 11234446.
DOI: 10.1002/advs.202402208.
RGD targeted magnetic ferrite nanoparticles enhance antitumor immunotherapeutic efficacy by activating STING signaling pathway.
Shi G, Liu X, Du Y, Tian J
iScience. 2024; 27(5):109062.
PMID: 38660408
PMC: 11039334.
DOI: 10.1016/j.isci.2024.109062.
Harnessing the cGAS-STING pathway to potentiate radiation therapy: current approaches and future directions.
Colangelo N, Gerber N, Vatner R, Cooper B
Front Pharmacol. 2024; 15:1383000.
PMID: 38659582
PMC: 11039815.
DOI: 10.3389/fphar.2024.1383000.
injectable hydrogel encapsulating Mn/NO-based immune nano-activator for prevention of postoperative tumor recurrence.
Huang S, Zhou C, Song C, Zhu X, Miao M, Li C
Asian J Pharm Sci. 2024; 19(2):100901.
PMID: 38645467
PMC: 11031726.
DOI: 10.1016/j.ajps.2024.100901.
Role of STING in the treatment of non-small cell lung cancer.
Tang W, Zhou W, Ji M, Yang X
Cell Commun Signal. 2024; 22(1):202.
PMID: 38566036
PMC: 10986073.
DOI: 10.1186/s12964-024-01586-x.
Update on the STING Signaling Pathway in Developing Nonalcoholic Fatty Liver Disease.
Liu W, Zhang Chen Z, Yang C, Fan Y, Qiao L, Xie S
J Clin Transl Hepatol. 2024; 12(1):91-99.
PMID: 38250469
PMC: 10794270.
DOI: 10.14218/JCTH.2023.00197.
Nanoenabled Intracellular Metal Ion Homeostasis Regulation for Tumor Therapy.
Xu L, Peng M, Gao T, Wang D, Lian X, Sun H
Adv Sci (Weinh). 2023; 11(7):e2306203.
PMID: 38063781
PMC: 10870045.
DOI: 10.1002/advs.202306203.
Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy.
Dong Q, Xue T, Yan H, Liu F, Liu R, Zhang K
J Nanobiotechnology. 2023; 21(1):395.
PMID: 37899463
PMC: 10614396.
DOI: 10.1186/s12951-023-02152-2.
Injectable biocompatible nanocomposites of Prussian blue nanoparticles and bacterial cellulose as a safe and effective photothermal cancer therapy.
Hong H, Kim M, Lee W, Jeon M, Lee C, Kim H
J Nanobiotechnology. 2023; 21(1):365.
PMID: 37798714
PMC: 10552393.
DOI: 10.1186/s12951-023-02108-6.
Lipid-based nanoparticles as drug delivery systems for cancer immunotherapy.
Hao Y, Ji Z, Zhou H, Wu D, Gu Z, Wang D
MedComm (2020). 2023; 4(4):e339.
PMID: 37560754
PMC: 10407046.
DOI: 10.1002/mco2.339.